Development of Appropriate Pediatric Formulations
and Pediatric Drug Delivery Systems

(R01with companion FOA:R03, R21, R41, R43)


The purpose of this Funding Opportunity Announcement (FOA) is to address different and complementary research needs for the development and acceptability of pediatric drug formulations in different age groups.

Development and testing of novel pediatric drug delivery systems is also part of this initiative.

Standard application deadlines apply. 

Visit the NIH web site for more details: